CCO Expert Recap

Early Breast Cancer: Endocrine Therapy

Source: CCO Independent Conference Coverage of the CCO Independent Conference Coverage of the 2007 San Antonio Breast Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Early Breast Cancer: Endocrine Therapy

Faculty:

Harold J. Burstein, MD, PhD

CREDIT INFORMATION

Release Date: February 27, 2008

Expiration Date: February 26, 2009

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the results of recent studies of adjuvant and neoadjuvant chemotherapy for the treatment of breast cancer
Discuss therapies designed to preserve the musculoskeletal health for women on hormonal therapy
Describe how CYP2D6 polymorphisms may affect the efficacy of tamoxifen in women with estrogen receptor–positive breast cancer

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.